Since our founding in 2004, we have raised approximately $87 million in equity funding, and received $105 million in milestones from our partnership with Forest Laboratories, as well as $5 million from other sources. Our investors include:

mohr-davidow aeris_capital dag_ventures
northgatecapital OntarioTeachersPensionPlan granitepointcapital

Adamas is driven to advance its portfolio of novel therapeutics for central nervous system disorders. Learn more